Structural dynamics of HIV-1 envelope GP120 outer domain with V3 loop

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Yokoyama, Masaru ^a   Naganawa, Satoshi ^b   Yoshimura, Kazuhisa ^c   Matsushita, Shuzo ^c   Sato, Hironori ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; HIV ENVELOPE PROTEIN GP120 (305 321); HIV ENVELOPE PROTEIN GP120 (305-321); PEPTIDE FRAGMENT;

ARTICLE; CLONE; ELECTRICAL PARAMETERS; ENTROPY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NET CHARGE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; V3 LOOP; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC VARIABILITY; GENETICS; HELA CELL; HUMAN; MOLECULAR GENETICS; SERODIAGNOSIS; STATIC ELECTRICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; GENETIC VARIATION; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; STATIC ELECTRICITY;

EID: 84862095730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037530     Document Type: Article

References (63)

1. Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, et al. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-1028.
2. Huang CC, Lam SN, Acharya P, Tang M, Xiang SH, et al. (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317: 1930-1934.
3. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135-1148.
4. Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, et al. (1997) Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 71: 7136-7139.
5. Xiao L, Owen SM, Goldman I, Lal AA, deJong JJ, et al. (1998) CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240: 83-92.
6. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, et al. (1998) Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 72: 2509-2515.
7. Goudsmit J, Debouck C, Meloen RH, Smit L, Bakker M, et al. (1988) Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A 85: 4478-4482.
8. Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, et al. (1988) Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A 85: 3198-3202.
9. Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, et al. (1989) Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A 86: 6768-6772.
10. Cavacini LA, Duval M, Robinson J, Posner MR, (2002) Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. Aids 16: 2409-2417.
11. Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, et al. (2005) Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. J Virol 79: 6957-6968.
12. Bou-Habib DC, Roderiquez G, Oravecz T, Berman PW, Lusso P, et al. (1994) Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J Virol 68: 6006-6013.
13. Naganawa S, Yokoyama M, Shiino T, Suzuki T, Ishigatsubo Y, et al. (2008) Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS One 3: e3206.
14. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR, (1992) Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257: 535-537.
15. Willey RL, Theodore TS, Martin MA, (1994) Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J Virol 68: 4409-4419.
16. Willey RL, Martin MA, Peden KW, (1994) Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. J Virol 68: 1029-1039.
17. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659.
18. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, et al. (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66: 3183-3187.
19. Chesebro B, Wehrly K, Nishio J, Perryman S, (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 66: 6547-6554.
20. Milich L, Margolin B, Swanstrom R, (1993) V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol 67: 5623-5634.
21. Milich L, Margolin BH, Swanstrom R, (1997) Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology 239: 108-118.
22. de Jong J-J, de Ronde A, Keulen W, Tersmette M, Goudsmit J, (1992) Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 66: 6777-6780.
23. Shioda T, Oka S, Ida S, Nokihara K, Toriyoshi H, et al. (1994) A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J Virol 68: 7689-7696.
24. Kato K, Sato H, Takebe Y, (1999) Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. J Virol 73: 5520-5526.
25. Thorpe IF, Brooks CL, 3rd, (2007) Molecular evolution of affinity and flexibility in the immune system. Proc Natl Acad Sci U S A 104: 8821-8826.
26. Lu HP, Xun L, Xie XS, (1998) Single-molecule enzymatic dynamics. Science 282: 1877-1882.
27. Astumian RD, (1997) Thermodynamics and kinetics of a Brownian motor. Science 276: 917-922.
28. Garcia-Viloca M, Gao J, Karplus M, Truhlar DG, (2004) How enzymes work: analysis by modern rate theory and computer simulations. Science 303: 186-195.
29. Karplus M, Kuriyan J, (2005) Molecular dynamics and protein function. Proc Natl Acad Sci U S A 102: 6679-6685.
30. Dodson GG, Lane DP, Verma CS, (2008) Molecular simulations of protein dynamics: new windows on mechanisms in biology. EMBO Rep 9: 144-150.
31. Miyamoto T, Yokoyama M, Kono K, Shioda T, Sato H, et al. (2011) A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5alpha. PLoS One 6: e22779.
32. Ode H, Yokoyama M, Kanda T, Sato H, (2011) Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability. J Mol Model 17: 391-399.
33. Baker D, Sali A, (2001) Protein structure prediction and structural genomics. Science 294: 93-96.
34. Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, et al. (2005) The Amber biomolecular simulation programs. J Comput Chem 26: 1668-1688.
35. Sato H, Kato K, Takebe Y, (1999) Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop. Virology 257: 491-501.
36. Hachiya A, Aizawa-Matsuoka S, Tanaka M, Takahashi Y, Ida S, et al. (2001) Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5). Antimicrob Agents Chemother 45: 495-501.
37. di Marzo Veronese F, Rahman R, Pal R, Boyer C, Romano J, et al. (1992) Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 8: 1125-1132.
38. Simmonds P, Balfe P, Ludlam CA, Bishop JO, Brown AJ, (1990) Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 64: 5840-5850.
39. Burns DP, Desrosiers RC, (1994) Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr Top Microbiol Immunol 188: 185-219.
40. Bonhoeffer S, Holmes SE, Nowak M, (1995) Causes of HIV diversity. Nature 376: 125.
41. Lukashov VV, Kuiken CL, Goudsmit J, (1995) Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol 69: 6911-6916.
42. Buonaguro L, Tornesello ML, Buonaguro FM, (2007) Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 81: 10209-10219.
43. Brown LS, Kamikubo H, Zimanyi L, Kataoka M, Tokunaga F, et al. (1997) A local electrostatic change is the cause of the large-scale protein conformation shift in bacteriorhodopsin. Proc Natl Acad Sci U S A 94: 5040-5044.
44. Wu SR, Loving R, Lindqvist B, Hebert H, Koeck PJ, et al. (2010) Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proc Natl Acad Sci U S A 107: 18844-18849.
45. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, et al. (2010) Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog 6: e1001249.
46. Hu G, Liu J, Taylor KA, Roux KH, (2011) Structural comparison of HIV-1 envelope spikes with and without the V1/V2 loop. J Virol 85: 2741-2750.
47. McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, et al. (2012) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480: 336-343.
48. Shibata J, Yoshimura K, Honda A, Koito A, Murakami T, et al. (2007) Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate. J Virol 81: 3757-3768.
49. Ogert RA, Lee MK, Ross W, Buckler-White A, Martin MA, et al. (2001) N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 75: 5998-6006.
50. Kwon YD, Finzi A, Wu X, Dogo-Isonagie C, Lee LK, et al. (2012) Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A 109: 5663-5668.
51. Sanchez R, Pieper U, Melo F, Eswar N, Marti-Renom MA, et al. (2000) Protein structure modeling for structural genomics. Nat Struct Biol 7 (Suppl): 986-990.
52. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325.
53. Ponder JW, Case DA, (2003) Force fields for protein simulations. Adv Protein Chem 66: 27-85.
54. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, et al. (2006) AMBER 9. University of California: San Francisco.
55. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, et al. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65: 712-725.
56. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
57. Ryckaert JP, Ciccotti G, Berendsen HJC, (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys 23: 327-341.
58. Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, et al. (1988) Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol 62: 2107-2114.
59. Yoshimura K, Harada S, Shibata J, Hatada M, Yamada Y, et al. (2010) Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds. J Virol.
60. Shiino T, Kato K, Kodaka N, Miyakuni T, Takebe Y, et al. (2000) A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure. J Virol 74: 1069-1078.
61. Motomura K, Oka T, Yokoyama M, Nakamura H, Mori H, et al. (2008) Identification of monomorphic and divergent haplotypes in the 2006-2007 norovirus GII/4 epidemic population by genomewide tracing of evolutionary history. J Virol 82: 11247-11262.
62. Oka T, Yokoyama M, Katayama K, Tsunemitsu H, Yamamoto M, et al. (2009) Structural and biological constraints on diversity of regions immediately upstream of cleavage sites in calicivirus precursor proteins. Virology 394: 119-129.
63. Shannon CE, (1997) The mathematical theory of communication. 1963. MD Comput 14: 306-317.